USPTO serial 79182843
RESISTANCE +
Reviewed by CopyMark Law Group
Reg. 5220219Status 404
- Filing date
- Status date
- Registration date
- Jun 13, 2017
- Examiner
- MURRAY, DAVID T
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with RESISTANCE +?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Eveleigh NSW 2015, AU
Eveleigh NSW 2015, AU
Eveleigh NSW 2015, AU
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David M. Perry
DAVID M. PERRY BLANK ROME LLP1 LOGAN SQPHILADELPHIA, PA 19103-6998UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry, science, photography; chemicals used in agriculture, horticulture and forestry except fungicides, herbicides, insecticides, and parasiticides; chemical reagents and reactants in this class for non-medical purposes; enzymes for industrial purposes, namely, for use in the biotechnology industry; nucleic acid sequences, other than medical and veterinary purposes; nucleic recombinant acids; acids, namely, inorganic acids; organic acids for use in the biotechnology industry; DNA polymerase, other than medical and veterinary purposes; chemicals used in food processing and screening; chemicals used in environmental monitoring | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical and veterinary preparations and substances for the diagnosis of diseases or detection or identification of pathogens for medical and veterinary purposes; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes for the diagnosis of diseases or detection or identification of pathogens; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens; enzymes for pharmaceutical, veterinary and medical purposes; medical kits in this class consisting of catalytic DNA molecules and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; diagnostic reagents for medical or veterinary use; biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders | SECTION 71 - CANCELLED | — |
| 010 | Surgical, medical and veterinary apparatus and instruments, namely, surgical apparatus and instruments for medical or veterinary use; diagnostic testing apparatus and instruments for medical purposes, namely, for the detection of diseases, detection and identification of pathogens, detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders, for genotyping, for analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; point of care medical devices for the detection of diseases, detection and identification of pathogens, detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders, for genotyping, for analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; medical screening apparatus in this class for the detection of diseases, detection and identification of pathogens, detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders, for genotyping, for analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SpeeDx Pty Ltd
- Other trademarks owned by SpeeDx Pty Ltd
- Other trademarks owned by SpeeDx Pty Ltd
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named RESISTANCE +
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 25, 2026 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Jun 25, 2026 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Sep 29, 2024 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 6, 2024 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Sep 6, 2024 | INPC | INVALIDATION PROCESSED | — |
| Aug 30, 2024 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 29, 2023 | C71T | CANCELLED SECTION 71 | — |
| Jun 13, 2022 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 28, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 20, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 20, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 13, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 13, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 28, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 28, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 10, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 8, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 22, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 13, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 13, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 13, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 13, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 13, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 10, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 7, 2017 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 7, 2017 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 7, 2017 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 1, 2017 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 1, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 1, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 1, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 1, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 1, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 23, 2017 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| Dec 16, 2016 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 1, 2016 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Sep 16, 2016 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 16, 2016 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 16, 2016 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 15, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 15, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 10, 2016 | ALIE | ASSIGNED TO LIE | — |
| Sep 2, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 19, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 2, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 2, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 2, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 1, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 29, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 27, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 23, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 22, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |